280 W River Park Dr Suite 110 Provo, Utah 84604

Dr. Jaycie Loewen



Director of Clinical and Research Operations

Dr. Jaycie Loewen is a Clinical Neuroscientist who received her Doctorate of Neuroscience at the University of Utah. Her background includes the study of basic and clinical brain injury, including the publication of research regarding mechanisms of epilepsy pathophysiology and collaboration with Utah’s Anticonvulsant Drug Discovery Laboratory. Her work has elucidated the role of glial and neuronal profiles in viral-induced brain injury and acute seizures. Dr. Loewen is a Howard Hughes Medical Institute Scholar, with a Master's in Clinical Investigation awarded in 2018, as well as a recipient of the Higher Education Teaching Specialist Certificate.


Dr. Loewen has presented at numerous large conferences during her time at Cognitive FX, including the International Brain Injury Association World Congress. She, Dr. Alina Fong, and Dr. Mark Allen have collaborated with the CDC to author a paper on neuroimaging in pediatric mild traumatic injury patients in 2020. Dr. Loewen currently aids in literature analysis and publication of scientific articles for the clinic, as well as conducting research – including that on COVID-19’s effects on the brain. Alongside also providing patient care, Dr. Loewen has taught graduate neurobiology classes at Brigham Young University, facilitates blog and video content for Cognitive FX, and mentors research interns.



  • The Identification and Assessment of Latent Subgroups in Post-Concussion Syndrome in Novel Treatment Setting. Holbrook LR, Fong AK, Allen MD, Loewen JL, Hill K.
  • In preparation Neuroimaging in Pediatric Patients with Mild Traumatic Brain Injury: Relating the Current 2018 Centers for Disease Control Guideline and the Potential of Advanced Neuroimaging Modalities for Research and Clinical Biomarker Development. Fong AK, Allen MD, Waltzman D, Sarmiento K, Yeates KO, Suskauer S, Wintermark M, Lindberg DM, Tate DF, Wilde EA, Loewen JL. J Neurotrauma. 2021 Jan 1;38(1):44-52. doi: 10.1089/neu.2020.7100.
  • Genetic and pharmacological manipulation of glial glutamate transporters does not alter infection-induced seizure activity. Loewen JL, Albertini G, Dahle EJ, Sato H, Smolders IJ, Massie A, Wilcox KS. Exp Neurol. 2019 Aug;318:50-60. doi: 10.1016/j.expneurol.2019.04.010.
  • Neuronal Injury, Gliosis, and Glial Proliferation in Two Models of Temporal Lobe Epilepsy. Loewen JL, Barker-Haliski ML, Dahle EJ, White HS, Wilcox KS. J Neuropathol Exp Neurol. 2016 Apr;75(4):366-78. doi: 10.1093/jnen/nlw008.